Digital

Astellas Pharma Partners With AI Proteins in Computational Drug Discovery Deal Worth Over USD 400 Million – Access to Miniprotein Design Platform to Strengthen Early-Stage Pipeline
AIAI Proteins

Astellas Pharma Partners With AI Proteins in Computational Drug Discovery Deal Worth Over USD 400 Million – Access to Miniprotein Design Platform to Strengthen Early-Stage Pipeline

Astellas Pharma Inc. (TYO: 4503) announced a collaboration with AI Proteins, a Boston‑based computational drug discovery company, in a deal with a total potential value exceeding USD 400 million. Under…

Insilico Medicine and MobiDrop Sign Strategic Partnership to Advance AI‑Ready Single‑Cell Data for Drug Discovery

Insilico Medicine and MobiDrop Sign Strategic Partnership to Advance AI‑Ready Single‑Cell Data for Drug Discovery

Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI‑Driven Patient Care in China

Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI‑Driven Patient Care in China

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
China Resource MedicineHealthcare Big Data

Roche Partners with China Resource Medicine to Promote Xofluza in China

Heren HealthSHA: 600763

Topchoice Medical to Acquire 19% Stake in Heren Health for $72.2M

J&JJohnson & Johnson

Zhongchao and Johnson & Johnson Renew Partnership for Digital Health Services

By-HealthCSO

By-Health Partners with Meituan’s Drug Purchase APP for New Retail Expansion

Show More